Evidence map›Paper›PMID 36594422›Full record

ArticleACS applied bio materials2023

Single-Particle Functionality Imaging of Antibody-Conjugated Nanoparticles in Complex Media.

Laura Woythe, Marrit M E Tholen, Bas J H M Rosier, Lorenzo Albertazzi

Abstract read
In one paragraph

Article in ACS applied bio materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Laura WoytheDepartment of Biomedical Engineering, Institute for Complex Molecular systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, Netherlands.ORCID 0000-0002-3125-130X
Marrit M E TholenDepartment of Biomedical Engineering, Institute for Complex Molecular systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, Netherlands.ORCID 0000-0002-4066-6064
Bas J H M RosierDepartment of Biomedical Engineering, Institute for Complex Molecular systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, Netherlands.ORCID 0000-0002-0062-7087
Lorenzo AlbertazziDepartment of Biomedical Engineering, Institute for Complex Molecular systems (ICMS), Eindhoven University of Technology, 5600 MB Eindhoven, Netherlands.ORCID 0000-0002-6837-0812

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The properties of nanoparticles (NPs) can change upon contact with serum components, occluding the NP surface by forming a biomolecular corona. It is believed that targeted NPs can lose their functionality due to this biological coating, thus losing specificity and selectivity toward target cells and leading to poor therapeutic efficiency. A better understanding of how the biomolecular corona affects NP ligand functionality is needed to maintain NP targeting capabilities. However, techniques that can quantify the functionality of NPs at a single-particle level in a complex medium are limited and often laborious in sample preparation, measurement, and analysis. In this work, the influence of serum exposure on the functionality of antibody-functionalized NPs was quantified using a straightforward total internal reflection fluorescence (TIRF) microscopy method and evaluated in cell uptake studies. The single-particle resolution of TIRF reveals the interparticle functionality heterogeneity and the substantial differences between NPs conjugated with covalent and noncovalent methods. Notably, only NPs covalently conjugated with a relatively high amount of antibodies maintain their functionality to a certain extent and still showed cell specificity and selectivity toward high receptor density cells after incubation in full serum. The presented study emphasizes the importance of single-particle functional characterization of NPs in complex media, contributing to the understanding and design of targeted NPs that retain their cell specificity and selectivity in biologically relevant conditions.

Indexed as

ImmunoconjugatesNanoparticlesProtein CoronaAntibodiesAntibodiesImmunoconjugatesProtein Coronaactive targetingbiomolecular coronacell selectivityheterogeneitynanoparticle conjugationTIRF microscopy

Identifiers

PMID36594422
PMCPMC9846673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.